We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Findings Implicate Circular RNA in the Development of Neurodegenerative Diseases

By LabMedica International staff writers
Posted on 28 Sep 2014
Print article
Image: Formation of circRNA—in this case circMbl—competes with the process of linear splicing (Photo courtesy of The Hebrew University of Jerusalem).
Image: Formation of circRNA—in this case circMbl—competes with the process of linear splicing (Photo courtesy of The Hebrew University of Jerusalem).
A recent paper described new findings that shed light on the production and function of circular RNA molecules (circRNA) in animal neuronal tissue.

CircRNA is a type of noncoding RNA that, unlike linear RNA, forms a covalently closed continuous loop. In circular RNA the 3' and 5' ends normally present in an RNA molecule have been joined together. This feature confers numerous properties to circular RNAs, many of which have only recently been identified. Though many of these circular RNAs arise from otherwise protein coding genes, circular RNAs produced in the cell have not been shown to code for proteins.

Investigators at The Hebrew University of Jerusalem (Israel) reported in the September 18, 2014, online edition of the journal Molecular Cell that animal circRNAs were generated co-transcriptionally and that their production rate was mainly determined by intronic sequences—filler DNA that separates coding regions on the chromosomes.

The investigators demonstrated that the process of circularization and that of normal splicing competed against each other, and that these mechanisms were tissue specific and conserved in animals. To further refine these findings, they concentrated on the gene for the protein muscleblind (muscleblind-like splicing regulator 1), which generates circularized RNA in flies and humans. They found that this circRNA (circMbl) and its flanking introns contained conserved muscleblind binding sites, which were strongly and specifically bound by muscleblind. Modulation of muscleblind levels strongly affected circMbl biosynthesis, and this effect was dependent on the muscleblind binding sites.

Since defects in muscleblind function have been linked to the severe degenerative disease myotonic dystrophy and since high levels of circRNAs are found in brain tissue, it may be that these molecules play a role in development of myotonic dystrophy and possibly other neurodegenerative diseases.

Senior author Dr. Sebastian Kadener, senior lecturer in biological chemistry at The Hebrew University of Jerusalem, said, "This research is significant from several perspectives. By mapping how circRNAs are produced, it helps advance our understanding of general molecular biology. In addition, it might be strongly relevant for understanding and eventually treating degenerative diseases both in muscle and the brain."

Related Links:

The Hebrew University of Jerusalem


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.